Videos

Study Supports the Need for Real-World Evidence to Better Manage CLL Patients

12/09/2020

Anthony Mato, MD, Memorial Sloan Kettering Cancer Center, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with chronic lymphocytic leukemia (CLL) in the clinical practice setting, using the informCLL prospective registry.

What's Trending?

News Connection

Patients’ Use of Multiple Acute Care Facilities

02/15/2011

Tori Socha

Timely access to patients’ health information is a key component in delivering effective and safe medical treatment.

Timely access to patients’...

02/15/2011

First Report Managed Care

News

TAVR may help recovery of cognitive function

10/19/2016

By David DouglasNEW YORK (Reuters Health) -...

...

10/19/2016

Population Health

News

FDA Approves New Drug to Treat Irritable Bowel Syndrome and Constipation

10/16/2012

On August 30, 2012, the FDA approved Linzess (linaclotide) for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C) in adults. Constipation is one of the most common gastrointestinal...

On August 30, 2012, the FDA...

10/16/2012

Annals of Long-Term Care

Conference Insider

Zarxio Switching Fails to Meet Budget Impact Model Expectations

05/10/2017

According to research presented at the AMCP 2017 Annual Meeting, Zarxio (filgrastim-sndz; Sandoz) cost savings, predicted using a budget impact model, failed to meet the expectations of researchers due to the drug’s higher price.

According to research presented...

05/10/2017

First Report Managed Care

News

Welcome to the AES 2017 Annual Meeting

11/29/2017

The 71st American Epilepsy Society (AES) Annual Meeting is taking place in Washington, DC, from December 1st through December 5th at the Walter E Washington Convention Center.

Study Supports the Need for Real-World Evidence to Better Manage CLL Patients

What's Trending?

Stay Informed—Sign up today!

Specialties

Events

Year Round Education

HMP Global Products